These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 21546262

  • 1. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E, Erozenci A, Smit J, Danesi R, Peters GJ.
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA and drug resistance.
    Ma J, Dong C, Ji C.
    Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
    [Abstract] [Full Text] [Related]

  • 3. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R, Hussey DJ, Haier J.
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [Abstract] [Full Text] [Related]

  • 4. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y.
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [Abstract] [Full Text] [Related]

  • 5. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs.
    Fojo T.
    Drug Resist Updat; 2007 Jun; 10(1-2):59-67. PubMed ID: 17350322
    [Abstract] [Full Text] [Related]

  • 6. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
    Kanakkanthara A, Miller JH.
    Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
    [Abstract] [Full Text] [Related]

  • 7. miRNAs modulate the drug response of tumor cells.
    Wu X, Xiao H.
    Sci China C Life Sci; 2009 Sep; 52(9):797-801. PubMed ID: 19802736
    [Abstract] [Full Text] [Related]

  • 8. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L, Gray SG, Finn SP, Cuffe S, O'Byrne KJ, Barr MP.
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [Abstract] [Full Text] [Related]

  • 9. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P.
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.
    Wei J, Xie L, Taron M, Rosell R, Liu B.
    Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.
    Husted S, Søkilde R, Rask L, Cirera S, Busk PK, Eriksen J, Litman T.
    Mol Pharm; 2011 Dec 05; 8(6):2055-62. PubMed ID: 21899346
    [Abstract] [Full Text] [Related]

  • 15. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
    Wang Q, Zhong M, Liu W, Li J, Huang J, Zheng L.
    Exp Lung Res; 2011 Sep 05; 37(7):427-34. PubMed ID: 21787234
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A, Jackson DB.
    Expert Rev Mol Diagn; 2011 Jul 05; 11(6):567-77. PubMed ID: 21745011
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of drug resistance.
    Longley DB, Johnston PG.
    J Pathol; 2005 Jan 05; 205(2):275-92. PubMed ID: 15641020
    [Abstract] [Full Text] [Related]

  • 19. MicroRNAs in an oral cancer context - from basic biology to clinical utility.
    Gorenchtein M, Poh CF, Saini R, Garnis C.
    J Dent Res; 2012 May 05; 91(5):440-6. PubMed ID: 22166582
    [Abstract] [Full Text] [Related]

  • 20. MicroRNAs as new therapeutic targets and tools in cancer.
    Gandellini P, Profumo V, Folini M, Zaffaroni N.
    Expert Opin Ther Targets; 2011 Mar 05; 15(3):265-79. PubMed ID: 21208133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.